166 related articles for article (PubMed ID: 18071292)
21. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome.
Tanosaki R; Uike N; Utsunomiya A; Saburi Y; Masuda M; Tomonaga M; Eto T; Hidaka M; Harada M; Choi I; Yamanaka T; Kannagi M; Matsuoka M; Okamura J
Biol Blood Marrow Transplant; 2008 Jun; 14(6):702-8. PubMed ID: 18489996
[TBL] [Abstract][Full Text] [Related]
22. Durable remission of Sézary syndrome after unrelated bone marrow transplantation by reduced-intensity conditioning.
Kahata K; Hashino S; Takahata M; Fujisawa F; Kondo T; Kobayashi S; Fujita Y; Shimizu H; Imamura M; Asaka M
Acta Haematol; 2008; 120(1):14-8. PubMed ID: 18716396
[TBL] [Abstract][Full Text] [Related]
23. Waldenström macroglobulinemia: a review of therapy.
Gertz MA
Am J Hematol; 2005 Jun; 79(2):147-57. PubMed ID: 15929102
[TBL] [Abstract][Full Text] [Related]
24. Autologous stem cell transplantation as part of first-line treatment of Waldenström's macroglobulinemia.
Dreger P; Schmitz N
Biol Blood Marrow Transplant; 2007 May; 13(5):623-4. PubMed ID: 17448924
[No Abstract] [Full Text] [Related]
25. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune thrombocytopenia with clonal expansion of CD8-positive T cells after autologous peripheral blood stem cell transplantation for diffuse large B-cell lymphoma.
Isobe T; Tanimoto TE; Nakaji G; Miyamoto T; Yamasaki S; Takase K; Numata A; Fukuda T; Nagafuji K; Inaba S; Harada M
Bone Marrow Transplant; 2005 Feb; 35(3):315-6. PubMed ID: 15568035
[No Abstract] [Full Text] [Related]
27. Sustained response after reduced-intensity conditioning allogeneic stem cell transplantation for patients with relapsed peripheral T-cell non-Hodgkin lymphoma.
de Lavallade H; Cassier PA; Bouabdallah R; El-Cheikh J; Faucher C; Fürst S; Coso D; Sainty D; Arnoulet C; Gastaut JA; Chetaille B; Xerri L; Blaise D; Mohty M
Br J Haematol; 2008 Sep; 142(5):848-50. PubMed ID: 18631344
[No Abstract] [Full Text] [Related]
28. The curability of follicular lymphoma.
Lunning M; Armitage JO
Transfus Apher Sci; 2007 Aug; 37(1):31-5. PubMed ID: 17936072
[TBL] [Abstract][Full Text] [Related]
29. Waldenström macroglobulinaemia: the key questions.
D'Souza A; Ansell S; Reeder C; Gertz MA
Br J Haematol; 2013 Aug; 162(3):295-303. PubMed ID: 23651417
[TBL] [Abstract][Full Text] [Related]
30. Management of refractory autoimmune hemolytic anemia via allogeneic stem cell transplantation.
Rotenstein L; Nathan A; Ghobrial I; Antin J; Parnes A
Bone Marrow Transplant; 2016 Nov; 51(11):1504-1506. PubMed ID: 27272445
[No Abstract] [Full Text] [Related]
31. Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab.
Steurer M; Clausen J; Gotwald T; Gunsilius E; Stockhammer G; Gastl G; Nachbaur D
Transplantation; 2003 Jul; 76(2):435-6. PubMed ID: 12883208
[No Abstract] [Full Text] [Related]
32. High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for multiple myeloma.
El-Cheikh J; Michallet M; Nagler A; de Lavallade H; Nicolini FE; Shimoni A; Faucher C; Sobh M; Revesz D; Hardan I; Fürst S; Blaise D; Mohty M
Haematologica; 2008 Mar; 93(3):455-8. PubMed ID: 18287132
[TBL] [Abstract][Full Text] [Related]
33. Primary CNS lymphoma--radiation-free salvage therapy by second autologous stem cell transplantation.
Kasenda B; Schorb E; Fritsch K; Hader C; Finke J; Illerhaus G
Biol Blood Marrow Transplant; 2011 Feb; 17(2):281-3. PubMed ID: 21093600
[No Abstract] [Full Text] [Related]
34. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
35. Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation.
Mohty M; Labopin M; Tabrizzi R; Theorin N; Fauser AA; Rambaldi A; Maertens J; Slavin S; Majolino I; Nagler A; Blaise D; Rocha V; ;
Haematologica; 2008 Feb; 93(2):303-6. PubMed ID: 18245655
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma.
Maloney D
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S35-S36. PubMed ID: 18724296
[TBL] [Abstract][Full Text] [Related]
37. Durable complete remission after chemotherapy and rituximab in a case of Waldenström's macroglobulinemia with pleuropulmonary involvement.
Capalbo S; Dargenio M; Delia M; Chiefa A; Diomede D; Napoli A; Ricco R; Liso V
Ann Hematol; 2005 Sep; 84(9):625-6. PubMed ID: 15915349
[No Abstract] [Full Text] [Related]
38. Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Sureda A; Robinson S; Canals C; Carella AM; Boogaerts MA; Caballero D; Hunter AE; Kanz L; Slavin S; Cornelissen JJ; Gramatzki M; Niederwieser D; Russell NH; Schmitz N
J Clin Oncol; 2008 Jan; 26(3):455-62. PubMed ID: 18086796
[TBL] [Abstract][Full Text] [Related]
39. Waldenstrom macroglobulinemia and simultaneous intravascular large B-cell lymphoma: Rare transformation or unhappy coincidence?
Kline KAF; Lee ST; Law JY; Kallen M
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e788-e791. PubMed ID: 35525836
[No Abstract] [Full Text] [Related]
40. Graft-Versus-Lymphoma Effect Can Be Rapid and Potent in Diffuse Large B-Cell Lymphoma.
Rashidi A; Cashen A
Exp Clin Transplant; 2016 Aug; 14(4):460-2. PubMed ID: 27506261
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
